Cargando…

High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation

BACKGROUND: The factors driving the onset and progression of ovarian cancer are not well understood. Recent reports have identified cell lines that are representative of the genomic pattern of high-grade serous ovarian cancer (HGSOC), in which greater than 90 % of tumors have a mutation in TP53. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgeois, Danielle L., Kabarowski, Karl A., Porubsky, Veronica L., Kreeger, Pamela K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672525/ https://www.ncbi.nlm.nih.gov/pubmed/26648788 http://dx.doi.org/10.1186/s12935-015-0263-4

Ejemplares similares

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
por: Zhu, Tingting, et al.
Publicado: (2020)

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
por: Fernandez, Marta Llaurado, et al.
Publicado: (2019)

Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
por: Zhang, Han, et al.
Publicado: (2021)

PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3
por: Soriano, Amata Amy, et al.
Publicado: (2019)

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
por: Cui, Ran, et al.
Publicado: (2019)

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
por: Azzalini, Eros, et al.
Publicado: (2023)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
por: Cooke, Susanna L, et al.
Publicado: (2010)

Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes
por: Micek, Hannah M., et al.
Publicado: (2023)

Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma
por: Huang, Wei, et al.
Publicado: (2020)

High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism
por: Braicu, Elena Ioana, et al.
Publicado: (2017)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
por: Schwarz, Roland F., et al.
Publicado: (2015)

The extracellular matrix of ovarian cortical inclusion cysts modulates invasion of fallopian tube epithelial cells
por: Fleszar, Andrew J., et al.
Publicado: (2018)

The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
por: Romani, Chiara, et al.
Publicado: (2021)

HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
por: Xu, Guocai, et al.
Publicado: (2021)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression
por: Mota, Alba, et al.
Publicado: (2015)

Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity
por: Sun, Tingting, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models
por: Heredia-Soto, Victoria, et al.
Publicado: (2022)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

Mutational heterogeneity in non-serous ovarian cancers
por: Teer, Jamie K., et al.
Publicado: (2017)

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
por: Sato, Sho, et al.
Publicado: (2023)

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
por: Subramanian, Deepak N., et al.
Publicado: (2020)

Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018)

Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
por: Yang, Bin, et al.
Publicado: (2022)

CAISMOV24, a new human low-grade serous ovarian carcinoma cell line
por: da Silva, Rodrigo Fernandes, et al.
Publicado: (2017)

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
por: Tudrej, Patrycja, et al.
Publicado: (2018)

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
por: Hunt, Allison L., et al.
Publicado: (2021)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas
por: Thu, Kelsie L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4fje4slh12b1rv0o5k6ov9ot7n